I am a
Home I AM A Search Login

Papers of the Week

Papers: 8 Oct 2022 - 14 Oct 2022

2022 Oct 13

Mol Pain

CXCR1 participates in bone cancer pain induced by Walker 256 breast cancer cells in female rats.


Xu C, Zhao B, Xu L, Wang Y, Liu B, Xu M, Qiuli H, Ni C, Fu J, Kong M, Lin X, Ni H, Yao M
Mol Pain. 2022 Oct 13:17448069221135743.
PMID: 36227008.


Bone cancer pain (BCP) is a clinically intractable mixed pain, involving inflammation and neuropathic pain, and its mechanisms remain unclear. CXC chemokine receptor 1 (CXCR1, IL-8RA) and 2 (CXCR2, IL-8RB) are high-affinity receptors for interleukin 8 (IL8). According to previous studies, CXCR2 plays a crucial role in BCP between astrocytes and neurons, while the role of CXCR1 remains unclear. The objective of this study was to investigate the role of CXCR1 in BCP. We found that CXCR1 expression increased in the spinal dorsal horn. Intrathecal injection of CXCR1 siRNA effectively attenuated mechanical allodynia and pain-related behaviors in rats. It was found that CXCR1 was predominantly co-localized with neurons. Intrathecal injection of CXCR1-siRNA reduced phosphorylated JAK2/STAT3 protein levels and the NLRP3 inflammasome (NLRP3, caspase1, and IL-1β) levels. Furthermore, in vitro cytological experiments confirmed this conclusion. The study results suggest that the spinal chemokine receptor CXCR1 activation mediates BCP through JAK2/STAT3 signaling pathway and NLRP3 inflammasome (NLRP3, caspase1, and IL-1β).